Tango Therapeutics, Inc. (TNGX) stock
TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$21.89−0.22 (-1.00%)
Close on Nov 18, 2026Market cap $3.69BP/E –Yield –
Tango Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Tango Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 0.7× to 11.5×, with a median of 2.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.2× | −1.9 |
| 2025 | Dec 31, 2025 | 6.2× | +4.7 |
| 2024 | Dec 31, 2024 | 1.4× | −2.2 |
| 2023 | Dec 29, 2023 | 3.6× | +1.3 |
| 2022 | Dec 30, 2022 | 2.3× | −0.3 |
| 2021 | Dec 31, 2021 | 2.6× | −0.8 |
| 2020 | Dec 31, 2020 | 3.4× | – |
See a number that looks wrong?